Bridgefront Capital’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Bridgefront Capital's CSTL Position: Q3 2026 in Review
Bridgefront Capital opened a new position in Castle Biosciences (CSTL) in Q3 2026: 12,282 shares worth $436K. The stake represents 0.1% of the portfolio and ranks #304 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in CSTL as recently as Q1 2021.
Bridgefront Capital first reported a position in CSTL in Q1 2021 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Bridgefront Capital held 12,282 shares of Castle Biosciences worth $436K as of Q3 2026.
- Castle Biosciences was a new Bridgefront Capital position in Q3 2026.
- Castle Biosciences made up 0.1% of Bridgefront Capital's portfolio in Q3 2026, its #304 holding.
- Bridgefront Capital first reported a position in Castle Biosciences in Q1 2021 and has held it in 2 quarters since.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Bridgefront Capital's 13F filing for Q3 2026, filed 16 Nov 2026.